The falling wedge is a bullish price formation that tells a tale of the stock where bulls are gearing up for a new rally.
+
PFE
is trading below my estimate of fair value ($68.47). OVERSOLD!
+ Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
+
PFE
is trading below my estimate of fair value ($68.47). OVERSOLD! + Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
Komentarz:
Back to Trendline
Komentarz:
Going up now
Komentarz:
Retesting the Orange line :)
Healthy way to go up
Healthy way to go up